Glenmark Pharma gets ANDA approval for Fulvestrant Injection

Glenmarks current portfolio consists of 159 products authorized for distribution in the US marketplace and 56 ANDAs pending approval with the USFDA.

from India Infoline News Service https://ift.tt/2zcGad1